Advantage Alpha Capital Partners’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,617
Closed -$63.5K 167
2024
Q3
$63.5K Buy
+23,617
New +$63.5K 0.01% 166